Estimation of manufacturing development costs of cell-based therapies: a feasibility study

Cell-based therapies (CBTs) provide opportunities to treat rare and high-burden diseases. Manufacturing development of these innovative products is said to be complex and costly. However, little research is available providing insight into resource use and cost drivers. Therefore, this study aimed t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cytotherapy (Oxford, England) England), 2021-08, Vol.23 (8), p.730-739
Hauptverfasser:	ten Ham, Renske M.T., Nievaart, Julianne C., Hoekman, Jarno, Cooper, Rachel S., Frederix, Geert W.J., Leufkens, Hubert G.M., Klungel, Olaf H., Ovelgönne, Hans, Hoefnagel, Marcel H.N., Turner, Marc L., Mountford, Joanne C.
Format:	Artikel
Sprache:	eng
Schlagworte:	cell therapies cell-based therapies costs development manufacturing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!